Brief: Aelis Farma FY Operating Loss Turns To Profit Of Eur 2.6 Mln

Aelis Farma SA

04/04/2022 06:18

April 4 (Reuters) - Aelis Farma SA  AELIS.PA :
    * NET RESULT FOR 2021 IS PROFIT OF €574K COMPARED TO LOSS OF
€2,086K FOR THE PREVIOUS YEAR
    * OPERATING RESULT AT END-2021 SHOWS A PROFIT OF €2,552K
COMPARED
TO A LOSS OF €2,840K AT END-2020
    * INTENDS TO CONTINUE THE DEVELOPMENT OF ITS VARIOUS ASSETS
AND
ACCELERATE THE DEVELOPMENT OF CB1-SSI
    * DEVELOPMENT OF AEF117 TO TREAT THE ADVERSE EFFECTS OF
CANNABIS
ABUSE: PHASE 2B TRIAL TO START IN Q2 2022
    * DEVELOPMENT OF AEF0217 TO TREAT VARIOUS COGNITIVE
DEFICITS,
INCLUDING THOSE OF DOWN SYNDROME: PHASE 1 STUDY RESULTS PLANNED
Q2 2022

Source text for Eikon:  ID:nBw70LW2Ba 
Further company coverage:  AELIS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))